Skip to main content

Table 2 Studies That Assessed Outcome of PSMA PET/CT-based SRT

From: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

Author

Year

n

Response rate

Median follow-up (months)

Henkenberens

2017

23

79%

12.4

Zschaeck

2017

20

60%

29

Emmett

2017

99

72%

10.5

Schmidt-Hegemann

2018

129

83%

20

Schmidt-Hegemann

2018

90

78%

23